| SANTHERA PHARM.HD.NA SF 1 | 13.700 |
| Date/Time | 06/28 / 15:58 |
| Chg. / Chg.(%) | - / |
| Bid | - |
| Ask | - |
| Open | 13.640 |
| Previous Close | 13.640 |
| High | 13.720 |
| Low | 13.640 |
| Volume [EUR] | 0.000 |
| Volume [Units] | 0 |
| Price fixings | 4 |
| ISIN | CH0027148649 |
| Security | S3F |
| Exchange | München |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 1.3300 |  |
40,329 |
| Lang & Schwa.. | 1.28 | |
|
| London Domes.. | 1.292 | 46 | |
| Cboe Europe .. | 1.31 | 475 | |
| Cboe Europe .. | 1.34 | 50 | |
| Turquoise | 1.31 |  |
57 |
| Nasdaq Other.. | 1.4100 | 500 | |
| TradeGate | 13.76 | 1,110 | |
| München | 13.700 | 0 | |
| Berlin | 13.720 | 0 | |
| Frankfurt | 13.6400 | 0 | |
| gettex | 13.880 |
News
- Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy
03/29/2022 / 07:00 - GlobeNewswire - Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference
03/15/2022 / 07:05 - GlobeNewswire - Santhera Completes Ordinary Capital Increase to Create Treasury Shares for Future Financing
03/15/2022 / 07:00 - GlobeNewswire - Santhera Announces Preliminary 2021 Financial Results and Increases Issued Share Capital to Create Treasury Shares for Future Financing
03/11/2022 / 07:00 - GlobeNewswire - Santhera Signs Gene Therapy Agreement with SEAL Therapeutics
02/28/2022 / 07:00 - GlobeNewswire
Real-time